Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

The RTS,S/AS01 malaria vaccine (Mosquirix) reduces the incidence of Plasmodium falciparum malaria and is intended for routine administration to infants in Sub-Saharan Africa. We evaluated the immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate...

Descripción completa

Detalles Bibliográficos
Autores principales: Valéa, Innocent, Adjei, Samuel, Usuf, Effua, Traore, Ousmane, Ansong, Daniel, Tinto, Halidou, Owusu Boateng, Harry, Leach, Amanda, Mwinessobaonfou Some, Athanase, Buabeng, Patrick, Vekemans, Johan, Nana, Louis Arnaud, Kotey, Amos, Vandoolaeghe, Pascale, Ouedraogo, Florence, Sambian, David, Lievens, Marc, Tahita, Marc Christian, Rettig, Theresa, Jongert, Erik, Lompo, Palpouguini, Idriss, Ali, Borys, Dorota, Ouedraogo, Sayouba, Prempeh, Frank, Habib, Md Ahsan, Schuerman, Lode, Sorgho, Hermann, Agbenyega, Tsiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037440/
https://www.ncbi.nlm.nih.gov/pubmed/29630438
http://dx.doi.org/10.1080/21645515.2018.1442996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037440/
https://www.ncbi.nlm.nih.gov/pubmed/29630438
http://dx.doi.org/10.1080/21645515.2018.1442996

Ejemplares similares